Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 29,527,550 | 25,914,240 | 22,476,320 | 22,337,810 | 19,680,020 |
| Cost of Goods | 12,612,020 | 11,422,050 | 9,815,147 | 10,641,110 | 8,884,157 |
| Gross Profit | 16,915,530 | 14,492,190 | 12,661,170 | 11,696,700 | 10,795,860 |
| Operating Expenses | 11,221,710 | 9,913,690 | 10,619,100 | 7,334,540 | 6,897,700 |
| Operating Income | 5,693,839 | 4,578,545 | 2,042,219 | 4,362,268 | 3,898,320 |
| Interest Expense | 528,474 | 456,390 | 292,347 | 153,662 | 149,087 |
| Other Income | 690,921 | 347,493 | 526,498 | 411,314 | 376,367 |
| Pre-tax Income | 5,856,286 | 4,469,648 | 2,276,370 | 4,619,920 | 4,125,600 |
| Income Tax | 1,122,070 | 863,334 | 559,615 | 1,247,855 | 949,764 |
| Net Income Continuous | 4,734,216 | 3,606,314 | 1,716,755 | 3,372,065 | 3,175,836 |
| Net Income Discontinuous | 146,503 | N/A | N/A | N/A | 60,015 |
| Net Income | $4,880,719 | $3,606,314 | $1,716,755 | $3,372,065 | $3,235,851 |
| EPS Basic Total Ops | 3.16 | 2.34 | 1.12 | 2.17 | 2.07 |
| EPS Basic Continuous Ops | 3.06 | 2.34 | 1.12 | 2.17 | 2.03 |
| EPS Basic Discontinuous Ops | 0.10 | N/A | N/A | N/A | 0.04 |
| EPS Diluted Total Ops | 3.12 | 2.31 | 1.12 | 2.16 | 2.06 |
| EPS Diluted Continuous Ops | 3.03 | 2.31 | 1.12 | 2.16 | 2.02 |
| EPS Diluted Discontinuous Ops | 0.09 | N/A | N/A | N/A | 0.04 |
| EBITDA(a) | $7,532,667 | $6,433,431 | $3,600,969 | $5,721,208 | $5,187,021 |